---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-314767"
form_type: "8-K"
ticker: "STIM"
cik: "0001227636"
company_name: "Neuronetics, Inc."
filed_at: "2022-12-29T23:59:59+00:00"
generated_at: "2026-06-20T21:47:59.468534+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Neuronetics appoints Joseph H. Capper to board, adopts amended bylaws

## Summary
- Joseph H. Capper appointed to board and Audit Committee effective Jan 1, 2023; term expires at 2023 annual meeting.
- Capper qualifies as independent under SEC and Nasdaq rules.
- Fourth Amended and Restated Bylaws adopted to update for universal proxy rules and administrative changes.
- Capper has no family relationships with directors/executives and no material interest in transactions.
- Capper to receive standard non-employee director compensation per 2022 proxy statement.

## SEC filing metadata
- accession: 0001193125-22-314767
- form_type: 8-K
- ticker: STIM
- cik: 0001227636
- company_name: Neuronetics, Inc.
- filed_at: 2022-12-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1227636/000119312522314767/0001193125-22-314767-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1227636/000119312522314767/d439589d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-314767
- JSON: https://secwatch.observer/filing/0001193125-22-314767.json
- Plain text: https://secwatch.observer/filing/0001193125-22-314767.txt

## Key facts
- Executive change
  Joseph H. Capper was appointed as Director at Neuronetics, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Joseph H. Capper as a director and member of the Board’s Audit Committee effective January 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1227636/000119312522314767/0001193125-22-314767-index.htm
- Governance Changes
  Neuronetics, Inc.: Adopted Fourth Amended and Restated Bylaws updating provisions for universal proxy rules and making administrative changes (effective 2022-12-27).
  - Change: bylaw amendment
  - Effective: 2022-12-27
  source text: On December 27, 2022, the Board voted to adopt the Fourth Amended and Restated Bylaws (the “A&R Bylaws”), which became effective immediately upon adoption. The A&R Bylaws amend and restate the Company’s previously existing bylaws in their entirety to, among other things, (i) update provisions as a result of universal proxy rules adopted by the SEC with respect to the nomination of directors for election, including a requirement for a stockholder submitting a nomination notice to make a representation as to whether such stockholder intends to solicit proxies in support of director nominees other than the Company’s nominees in accordance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and to provide reasonable evidence that certain requirements of such rule have been satisfied; and (ii) make certain other administrative, modernizing, clarifying and conforming changes.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1227636/000119312522314767/0001193125-22-314767-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.